These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6524301)

  • 1. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
    Owens D; Collins PB; Johnson A; Tomkin GH
    Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
    Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.
    Farish E; Fletcher CD; Hart DM; Kitchener H; Sharpe GL
    Clin Chim Acta; 1983 Aug; 132(2):193-8. PubMed ID: 6577991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
    Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
    Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women.
    Sporrong T; Hellgren M; Samsioe G; Mattsson LA
    Obstet Gynecol; 1989 May; 73(5 Pt 1):754-8. PubMed ID: 2704503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy.
    Farish E; Fletcher CD; Dagen MM; Hart DM; Al-Azzawi F; Parkin DE; Howie CA
    Br J Obstet Gynaecol; 1989 Mar; 96(3):358-64. PubMed ID: 2713295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.